{
    "id": "24pzpt7ajse2yvygk3fj4iqkdhkak7vl",
    "title": "ATXN1: expanding the spectrum of polyglutamine repeats in ALS",
    "info": {
        "author": [
            "Gijs Tazelaar, University Medical Center Utrecht, Utrecht University"
        ],
        "published": "July 21, 2017",
        "recorded": "May 2017",
        "category": [
            "Top->Medicine",
            "Top->Medicine->Neuroscience"
        ]
    },
    "url": "http://videolectures.net/encals2017_tazelaar_polyglutamine_repeats/",
    "segmentation": [
        [
            "So I do like to of course thank the organizing Committee for giving us the opportunity to present our ongoing research.",
            "And the other thing we're very grateful about is that today I won't be really telling something new or a new concept and will merely expand something which is already known.",
            "Of course, from the 8X and two story, and I think without going to to the end of the presentation, a lot of these Hollywood blockbusters or first successful sequels tend to be somewhat disappointing, and I hope that today this is not the case, but I'll leave that up to you.",
            "So."
        ],
        [
            "Our story starts.",
            "I think we all know what the LSS, but maybe some of you are what in familiar with polyglutamine expansions and polyglutamine expansions or polyglutamine stretches are a very common thing in neuronal proteins, and as Russell already explained, they have an unfortunate habit of expanding leading towards a polycule protein or disease protein which can affect multiple process is leading towards neurodegeneration.",
            "Phenotype, you get kind of depends on which gene is affected, so we know Huntington's, for instance.",
            "But I think in most of."
        ],
        [
            "Very common one or a very known one, Arda Spinal cerebella ataxia as it's a large group of disease, almost 30 different types depending on which gene is affected, but many of these are affected by this HCG expansion, so there's a list of the most common ones, and I think if we now look at the clinical symptoms which you see.",
            "You find something very interesting, I think to the LS people in his room, namely that it had they have an adult onset their progressive neurodegenerative disease.",
            "And of course they have cerebellar symptoms, which is their clinical hallmark, but they also have non cerebellar symptoms, which sounds familiar, such as hyperref, Lexia atrophy, infesta collations.",
            "However."
        ],
        [
            "Link between LS an polyglutamine disease was somewhat coincidental.",
            "When a group in the United States showed that a yeast TDP 43 toxicity screen, they had an increased toxicity using a orthologue of ATEX into, namely, PBP one.",
            "So of course the logical next question was to see whether they could."
        ],
        [
            "Find differences in this repeat in a less patients versus not neurologically normal controls and what they found is that within a few a range of normal.",
            "So if you have a really long stretch of this polyglutamine in a Texan two, you get scar two disease.",
            "But if you're in between the normal range and this car 2 range, you're actually have a higher increased risk for developing a LS.",
            "And they show that this is.",
            "This is significant, so this of course raises a lot of of the new questions and a lot of investigations were done.",
            "But they all."
        ],
        [
            "In the first article they already addressed the other public Eugene's, so they tested those, and they don't really provide us with which cut offs they used for intermediate expansions.",
            "So that's still interesting, but they didn't find any other Association for the other scar jeans, and also other CHD expansion jeans.",
            "So."
        ],
        [
            "Why did we revisit a tax in one?",
            "Well, we had a Dutch pedigree where there were a few scar one cases, and now there was a cousin with a LS.",
            "And of course this could be merely coincidental, but but I think though as a researcher you should not believe in coincidence issues trying to get something out of it.",
            "And if it's not true, then you find out later on."
        ],
        [
            "But we were not the first one to pick up on this.",
            "There's already a publication in 2012 and in 2014 by an Italian group, and they have a huge pent, agree with a lot of scar.",
            "One patients in black and one LS case in grey.",
            "Again, this could merely be coincidence."
        ],
        [
            "But the Italians had the same ideas that we had, namely that they tested a small cord of a LS patients and similar to the 8X and two.",
            "They find a range and they define it at 32 repeats and up to the red rain, so the intermediate range is overrepresented in there, a less scored.",
            "Again, this is significant, so going into this struggle going into this fight, I think we were fairly confident that we that our chances were great for winning."
        ],
        [
            "We must keep in mind that a Texan two and a Texan one, although they sound familiar, they're not the same proteins.",
            "So there are differences both genetically as well as in cell biology, and I think in most very important difference to emphasize here is that a text in one can be interrupted by a CHT and CHD actually codes for a different amino acid than the interruptions which are in a Texan two, which also code for glutamine.",
            "So if it really is a pure polyglutamine stretch, then you might be protected more in in the 8X in one.",
            "If you have these histidine interruptions.",
            "So both of them are.",
            "Interestingly, TDP 43 RNA targets already in literature described.",
            "However, this was only really studied 48 X and two of course.",
            "Of course this happened after the investigation with a LS."
        ],
        [
            "So our aim of the study, logically speaking, was to see whether we could find this increase of CHD CHD in a LS."
        ],
        [
            "So I think the nice thing about these kinds of conventions, as they always lead up to two consortium or groups which which work together so no longer were looking in one cohort.",
            "But we are actually looking in a very diverse code of the Dutch, French, Belgium and Ireland as well leading up to a large group of patients of over 2 1/2 thousand and almost as many controls.",
            "And I think if we look at the clinical characteristics were really looking at the population of a LS which we know from literature.",
            "So we have a nice kohorta test."
        ],
        [
            "And these so and then we of course have to test this, and since we're not in a tax in two or a Skylab, the first thing we did is we started why Singer Singer sequencing and the reason we do that is repeat prime PC or repeat PCR gives you a fragment size, but you really have to be confident it was fragmentized corresponds to.",
            "So Sanger sequencing has a lot of disadvantages that gives a lot of the artifacts and therefore local rate, so I will certainly would not advise for using that for the old sample, but it does provide you with the most common alleles.",
            "Really, by counting them, so you can't really make a mistake in fragment size there, so we use the output of the Sanger sequencing to test whether we were really predicting our repeat PCR well, and we then called all samples via automated blinded calling.",
            "So here you can see an example for the attacks in two days.",
            "How the repeat PCR works, you get 2 peaks, meaning both alleles and that will eventually you can calculate these fragment sizes towards repeat sizes."
        ],
        [
            "Now if we look at the distribution, this is the distribution which we get for a Texan one.",
            "And as I said, well now, well, this is kind of disappointing that we see in a Texan two, we see a control code of where you have really have a decrease of control above a certain color, but we don't see that clear decrease in 8X in one.",
            "So even at the higher range is we see also both a less patients in blue as well as controls our representative.",
            "But if you look really closely, although the differences are very small.",
            "From I think from 30 and up you can see that the LS cases are overrepresented in every category.",
            "So now we have to pick a cut off and we first tried this via RC analysis, but because of the differences are so small, the RC analysis is very flat and you get an advice of either picking to 32 or 33.",
            "So I think looking at the distribution."
        ],
        [
            "I think it's more logical to pick for free because at 32 you have a really high amount of both cases and controls, so if you pick if you put the color red 33 and higher then you get at least the allele frequency of your controls will be below 95%.",
            "So I think that that's the reason why we chose this cut off and I think the scientifically solid as well."
        ],
        [
            "So if we take this kind of what do we find?",
            "So now we're not looking at alleles, but we're looking at carriers.",
            "Then we see that about 12.3% of the LS patients were carrying a intermediate, a Texan one repeat expansion versus 10% in controls.",
            "So these were really high numbers compared to the 8X in two.",
            "And if we now look at the scene and off so we had a fairly large amount of CN patients 211, and what we see is we don't see any enrichment of the ATEX into would be into a Texan.",
            "One intermediate repeat in the scene of positive group.",
            "So you see similar similar distribution for the sine of negative, but for the positive ones you don't see a higher percentage.",
            "Of course these numbers are lower so you have a higher range of in confident."
        ],
        [
            "So if we now look at our Association analysis from all different cohorts and taking them together, we do find a significant P value for the 8X and one intermediate expansions within arts ratio of 1.3.",
            "And this is in both fixed and random effects models."
        ],
        [
            "If we now look at a Texan one and survival after onset, we can see there it might be some trend for towards the ones with the 8X and one being worse off.",
            "But if you correct for the known covariates, disinfectors is certainly not significant.",
            "Simmer."
        ],
        [
            "Two 8X and two.",
            "We don't see any effect at all at H onset.",
            "So yeah, I think this is.",
            "Again, normally with the HCG or the polycule diseases you see with longer expansions you get an early age of onset, but being in this intermediate region makes it more difficult to interpret these results, but we don't see anything popping up here."
        ],
        [
            "So coming to our preliminary conclusions, I think we showed that there is a significant Association in the increased length of the trinucleotide repeats in a Texan one and LS using a cut off at 30, three in a dominant model.",
            "We don't see any enrichment for tocino, nor of expanded area.",
            "Less individuals in the intermediate expansions, and we do not find a significant effect on survival.",
            "However, we do see, oh, and we also don't see any difference in age of onset."
        ],
        [
            "Now of course we come to the fun part, which is the discussion is why do we find these differences between a tax in one and a Texan?",
            "2?",
            "So I think the most striking differences, as I said, the frequency of these intermediate fractions, but within a Texan, one with respect to a Texan two which are way higher in a Texan one, and is also translate to a reduced polygenic to reduce the relative risk of a Texan one being much lower than the last Lee.",
            "Generated pools a Texan two data, so I think it's not only interesting to study the similarities between a Texan one and a Texan too, but mainly also differences.",
            "And again, as I stressed out in the beginning, one important differences might be the cat interruptions.",
            "And normally we geneticists tend to stop after we find an Association, but we did want to carry this forward so."
        ],
        [
            "We went to a lab with more experience in these kinds of and this is a little taste.",
            "So Stephen Boone Arms will always also be presenting tomorrow, not on this topic, by the way.",
            "Only tonight I think anyway, So what he already showed is that similar to a text into what we know from a Texan two that overexpressing the wild type, A text in one repeat expansion.",
            "You get a mislocalization of endogenous TDP 43 here staying in green.",
            "So here we have a cell which has decreased D TDP 43 staining in the nucleus and the translocation towards the cytoplasm.",
            "And if you quantify that, you do see a significant result.",
            "So a lot of more functional work is coming and I think it shows data which is similar similar to what we know from a Texan 2."
        ],
        [
            "So of course, a lot of people worked on this, and since this is also a collaboration, I think that's that's great, especially in the world of genetics, and I would like to thank all of the people who worked on this, especially also my supervisors and norm."
        ],
        [
            "I would say that that we've now arrived at the end of my talk, but I think now given also the story of Russell and then what we found that this would just be if we're considering repeats the end of the beginning, and I think it's interesting to also revisit all the other polyglutamine expansions or other repeats as well in a less.",
            "And with that I would like to thank you and open your for questions."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So I do like to of course thank the organizing Committee for giving us the opportunity to present our ongoing research.",
                    "label": 0
                },
                {
                    "sent": "And the other thing we're very grateful about is that today I won't be really telling something new or a new concept and will merely expand something which is already known.",
                    "label": 0
                },
                {
                    "sent": "Of course, from the 8X and two story, and I think without going to to the end of the presentation, a lot of these Hollywood blockbusters or first successful sequels tend to be somewhat disappointing, and I hope that today this is not the case, but I'll leave that up to you.",
                    "label": 0
                },
                {
                    "sent": "So.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Our story starts.",
                    "label": 0
                },
                {
                    "sent": "I think we all know what the LSS, but maybe some of you are what in familiar with polyglutamine expansions and polyglutamine expansions or polyglutamine stretches are a very common thing in neuronal proteins, and as Russell already explained, they have an unfortunate habit of expanding leading towards a polycule protein or disease protein which can affect multiple process is leading towards neurodegeneration.",
                    "label": 0
                },
                {
                    "sent": "Phenotype, you get kind of depends on which gene is affected, so we know Huntington's, for instance.",
                    "label": 0
                },
                {
                    "sent": "But I think in most of.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Very common one or a very known one, Arda Spinal cerebella ataxia as it's a large group of disease, almost 30 different types depending on which gene is affected, but many of these are affected by this HCG expansion, so there's a list of the most common ones, and I think if we now look at the clinical symptoms which you see.",
                    "label": 0
                },
                {
                    "sent": "You find something very interesting, I think to the LS people in his room, namely that it had they have an adult onset their progressive neurodegenerative disease.",
                    "label": 0
                },
                {
                    "sent": "And of course they have cerebellar symptoms, which is their clinical hallmark, but they also have non cerebellar symptoms, which sounds familiar, such as hyperref, Lexia atrophy, infesta collations.",
                    "label": 0
                },
                {
                    "sent": "However.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Link between LS an polyglutamine disease was somewhat coincidental.",
                    "label": 0
                },
                {
                    "sent": "When a group in the United States showed that a yeast TDP 43 toxicity screen, they had an increased toxicity using a orthologue of ATEX into, namely, PBP one.",
                    "label": 1
                },
                {
                    "sent": "So of course the logical next question was to see whether they could.",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Find differences in this repeat in a less patients versus not neurologically normal controls and what they found is that within a few a range of normal.",
                    "label": 0
                },
                {
                    "sent": "So if you have a really long stretch of this polyglutamine in a Texan two, you get scar two disease.",
                    "label": 0
                },
                {
                    "sent": "But if you're in between the normal range and this car 2 range, you're actually have a higher increased risk for developing a LS.",
                    "label": 0
                },
                {
                    "sent": "And they show that this is.",
                    "label": 0
                },
                {
                    "sent": "This is significant, so this of course raises a lot of of the new questions and a lot of investigations were done.",
                    "label": 0
                },
                {
                    "sent": "But they all.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "In the first article they already addressed the other public Eugene's, so they tested those, and they don't really provide us with which cut offs they used for intermediate expansions.",
                    "label": 0
                },
                {
                    "sent": "So that's still interesting, but they didn't find any other Association for the other scar jeans, and also other CHD expansion jeans.",
                    "label": 0
                },
                {
                    "sent": "So.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Why did we revisit a tax in one?",
                    "label": 0
                },
                {
                    "sent": "Well, we had a Dutch pedigree where there were a few scar one cases, and now there was a cousin with a LS.",
                    "label": 0
                },
                {
                    "sent": "And of course this could be merely coincidental, but but I think though as a researcher you should not believe in coincidence issues trying to get something out of it.",
                    "label": 0
                },
                {
                    "sent": "And if it's not true, then you find out later on.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "But we were not the first one to pick up on this.",
                    "label": 0
                },
                {
                    "sent": "There's already a publication in 2012 and in 2014 by an Italian group, and they have a huge pent, agree with a lot of scar.",
                    "label": 0
                },
                {
                    "sent": "One patients in black and one LS case in grey.",
                    "label": 1
                },
                {
                    "sent": "Again, this could merely be coincidence.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "But the Italians had the same ideas that we had, namely that they tested a small cord of a LS patients and similar to the 8X and two.",
                    "label": 0
                },
                {
                    "sent": "They find a range and they define it at 32 repeats and up to the red rain, so the intermediate range is overrepresented in there, a less scored.",
                    "label": 0
                },
                {
                    "sent": "Again, this is significant, so going into this struggle going into this fight, I think we were fairly confident that we that our chances were great for winning.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We must keep in mind that a Texan two and a Texan one, although they sound familiar, they're not the same proteins.",
                    "label": 0
                },
                {
                    "sent": "So there are differences both genetically as well as in cell biology, and I think in most very important difference to emphasize here is that a text in one can be interrupted by a CHT and CHD actually codes for a different amino acid than the interruptions which are in a Texan two, which also code for glutamine.",
                    "label": 0
                },
                {
                    "sent": "So if it really is a pure polyglutamine stretch, then you might be protected more in in the 8X in one.",
                    "label": 0
                },
                {
                    "sent": "If you have these histidine interruptions.",
                    "label": 0
                },
                {
                    "sent": "So both of them are.",
                    "label": 0
                },
                {
                    "sent": "Interestingly, TDP 43 RNA targets already in literature described.",
                    "label": 0
                },
                {
                    "sent": "However, this was only really studied 48 X and two of course.",
                    "label": 0
                },
                {
                    "sent": "Of course this happened after the investigation with a LS.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So our aim of the study, logically speaking, was to see whether we could find this increase of CHD CHD in a LS.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So I think the nice thing about these kinds of conventions, as they always lead up to two consortium or groups which which work together so no longer were looking in one cohort.",
                    "label": 0
                },
                {
                    "sent": "But we are actually looking in a very diverse code of the Dutch, French, Belgium and Ireland as well leading up to a large group of patients of over 2 1/2 thousand and almost as many controls.",
                    "label": 0
                },
                {
                    "sent": "And I think if we look at the clinical characteristics were really looking at the population of a LS which we know from literature.",
                    "label": 0
                },
                {
                    "sent": "So we have a nice kohorta test.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And these so and then we of course have to test this, and since we're not in a tax in two or a Skylab, the first thing we did is we started why Singer Singer sequencing and the reason we do that is repeat prime PC or repeat PCR gives you a fragment size, but you really have to be confident it was fragmentized corresponds to.",
                    "label": 0
                },
                {
                    "sent": "So Sanger sequencing has a lot of disadvantages that gives a lot of the artifacts and therefore local rate, so I will certainly would not advise for using that for the old sample, but it does provide you with the most common alleles.",
                    "label": 1
                },
                {
                    "sent": "Really, by counting them, so you can't really make a mistake in fragment size there, so we use the output of the Sanger sequencing to test whether we were really predicting our repeat PCR well, and we then called all samples via automated blinded calling.",
                    "label": 0
                },
                {
                    "sent": "So here you can see an example for the attacks in two days.",
                    "label": 0
                },
                {
                    "sent": "How the repeat PCR works, you get 2 peaks, meaning both alleles and that will eventually you can calculate these fragment sizes towards repeat sizes.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Now if we look at the distribution, this is the distribution which we get for a Texan one.",
                    "label": 0
                },
                {
                    "sent": "And as I said, well now, well, this is kind of disappointing that we see in a Texan two, we see a control code of where you have really have a decrease of control above a certain color, but we don't see that clear decrease in 8X in one.",
                    "label": 0
                },
                {
                    "sent": "So even at the higher range is we see also both a less patients in blue as well as controls our representative.",
                    "label": 0
                },
                {
                    "sent": "But if you look really closely, although the differences are very small.",
                    "label": 0
                },
                {
                    "sent": "From I think from 30 and up you can see that the LS cases are overrepresented in every category.",
                    "label": 0
                },
                {
                    "sent": "So now we have to pick a cut off and we first tried this via RC analysis, but because of the differences are so small, the RC analysis is very flat and you get an advice of either picking to 32 or 33.",
                    "label": 1
                },
                {
                    "sent": "So I think looking at the distribution.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I think it's more logical to pick for free because at 32 you have a really high amount of both cases and controls, so if you pick if you put the color red 33 and higher then you get at least the allele frequency of your controls will be below 95%.",
                    "label": 0
                },
                {
                    "sent": "So I think that that's the reason why we chose this cut off and I think the scientifically solid as well.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So if we take this kind of what do we find?",
                    "label": 0
                },
                {
                    "sent": "So now we're not looking at alleles, but we're looking at carriers.",
                    "label": 0
                },
                {
                    "sent": "Then we see that about 12.3% of the LS patients were carrying a intermediate, a Texan one repeat expansion versus 10% in controls.",
                    "label": 0
                },
                {
                    "sent": "So these were really high numbers compared to the 8X in two.",
                    "label": 0
                },
                {
                    "sent": "And if we now look at the scene and off so we had a fairly large amount of CN patients 211, and what we see is we don't see any enrichment of the ATEX into would be into a Texan.",
                    "label": 0
                },
                {
                    "sent": "One intermediate repeat in the scene of positive group.",
                    "label": 0
                },
                {
                    "sent": "So you see similar similar distribution for the sine of negative, but for the positive ones you don't see a higher percentage.",
                    "label": 0
                },
                {
                    "sent": "Of course these numbers are lower so you have a higher range of in confident.",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So if we now look at our Association analysis from all different cohorts and taking them together, we do find a significant P value for the 8X and one intermediate expansions within arts ratio of 1.3.",
                    "label": 0
                },
                {
                    "sent": "And this is in both fixed and random effects models.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "If we now look at a Texan one and survival after onset, we can see there it might be some trend for towards the ones with the 8X and one being worse off.",
                    "label": 1
                },
                {
                    "sent": "But if you correct for the known covariates, disinfectors is certainly not significant.",
                    "label": 0
                },
                {
                    "sent": "Simmer.",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Two 8X and two.",
                    "label": 0
                },
                {
                    "sent": "We don't see any effect at all at H onset.",
                    "label": 0
                },
                {
                    "sent": "So yeah, I think this is.",
                    "label": 0
                },
                {
                    "sent": "Again, normally with the HCG or the polycule diseases you see with longer expansions you get an early age of onset, but being in this intermediate region makes it more difficult to interpret these results, but we don't see anything popping up here.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So coming to our preliminary conclusions, I think we showed that there is a significant Association in the increased length of the trinucleotide repeats in a Texan one and LS using a cut off at 30, three in a dominant model.",
                    "label": 1
                },
                {
                    "sent": "We don't see any enrichment for tocino, nor of expanded area.",
                    "label": 0
                },
                {
                    "sent": "Less individuals in the intermediate expansions, and we do not find a significant effect on survival.",
                    "label": 0
                },
                {
                    "sent": "However, we do see, oh, and we also don't see any difference in age of onset.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Now of course we come to the fun part, which is the discussion is why do we find these differences between a tax in one and a Texan?",
                    "label": 0
                },
                {
                    "sent": "2?",
                    "label": 0
                },
                {
                    "sent": "So I think the most striking differences, as I said, the frequency of these intermediate fractions, but within a Texan, one with respect to a Texan two which are way higher in a Texan one, and is also translate to a reduced polygenic to reduce the relative risk of a Texan one being much lower than the last Lee.",
                    "label": 0
                },
                {
                    "sent": "Generated pools a Texan two data, so I think it's not only interesting to study the similarities between a Texan one and a Texan too, but mainly also differences.",
                    "label": 0
                },
                {
                    "sent": "And again, as I stressed out in the beginning, one important differences might be the cat interruptions.",
                    "label": 0
                },
                {
                    "sent": "And normally we geneticists tend to stop after we find an Association, but we did want to carry this forward so.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We went to a lab with more experience in these kinds of and this is a little taste.",
                    "label": 0
                },
                {
                    "sent": "So Stephen Boone Arms will always also be presenting tomorrow, not on this topic, by the way.",
                    "label": 0
                },
                {
                    "sent": "Only tonight I think anyway, So what he already showed is that similar to a text into what we know from a Texan two that overexpressing the wild type, A text in one repeat expansion.",
                    "label": 0
                },
                {
                    "sent": "You get a mislocalization of endogenous TDP 43 here staying in green.",
                    "label": 0
                },
                {
                    "sent": "So here we have a cell which has decreased D TDP 43 staining in the nucleus and the translocation towards the cytoplasm.",
                    "label": 0
                },
                {
                    "sent": "And if you quantify that, you do see a significant result.",
                    "label": 0
                },
                {
                    "sent": "So a lot of more functional work is coming and I think it shows data which is similar similar to what we know from a Texan 2.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So of course, a lot of people worked on this, and since this is also a collaboration, I think that's that's great, especially in the world of genetics, and I would like to thank all of the people who worked on this, especially also my supervisors and norm.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I would say that that we've now arrived at the end of my talk, but I think now given also the story of Russell and then what we found that this would just be if we're considering repeats the end of the beginning, and I think it's interesting to also revisit all the other polyglutamine expansions or other repeats as well in a less.",
                    "label": 0
                },
                {
                    "sent": "And with that I would like to thank you and open your for questions.",
                    "label": 0
                }
            ]
        }
    }
}